menu
    • menu

    Company profile for Cancer Prevention Pharmaceuticals

    NEW Drugs in Dev: 4
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cancer Prevention Pharmaceuticals is a clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases. CPP’s innovative technology addresses polyamine metabolism, immune regulation and inflammation to reduce cancer risk and impact other diseases. These two processes have long been implicated in cancer development but never successfully utilized together to exploit and treat can...
    Cancer Prevention Pharmaceuticals is a clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases. CPP’s innovative technology addresses polyamine metabolism, immune regulation and inflammation to reduce cancer risk and impact other diseases. These two processes have long been implicated in cancer development but never successfully utilized together to exploit and treat cancer precursors until now.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cancer Prevention PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1760E River Rd Tucson, Arizona 85718
    Telephone
    Telephone
    520.908.7774
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://canprevent.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cancer-prevention-pharmaceuticals-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Panbela Tx Closes Acquisition of Cancer Prevention Pharma
    Panbela Tx Closes Acquisition of Cancer Prevention Pharma

    16 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/16/2463907/37414/en/Panbela-Therapeutics-Inc-Closes-Acquisition-of-Cancer-Prevention-Pharmaceuticals-Inc.html

    GLOBENEWSWIRE
    16 Jun 2022
    Share Share
    Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
    Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.

    22 Feb 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/panbela-therapeutics-inc-to-acquire-cancer-prevention-pharmaceuticals-inc-/?s=79

    BIOSPACE
    22 Feb 2022
    Share Share
    Cancer Prevention Pharmaceuticals Publishes of Landmark Phase 3 Trial
    Cancer Prevention Pharmaceuticals Publishes of Landmark Phase 3 Trial

    11 Sep 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200911005051/en

    BUSINESS WIRE
    11 Sep 2020
    Share Share
    Cancer Prevention sNDA New Drug Application to the FDA for CPP-1X/sul
    Cancer Prevention sNDA New Drug Application to the FDA for CPP-1X/sul

    29 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200629005106/en

    BUSINESSWIRE
    29 Jun 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search